Ackermans & van Haaren

Davos '24: Bill Gates Joins Belgium in Showcase of Innovation and Global Partnerships

Retrieved on:

Wednesday, January 17, 2024

The Belgium House is an initiative from European Business Summits and a group of leading Belgian companies, with the support of the Belgian federal government, to showcase Belgian technology and innovation.

Key Points:

The Belgium House is an initiative from European Business Summits and a group of leading Belgian companies, with the support of the Belgian federal government, to showcase Belgian technology and innovation.
Prime Minister Alexander De Croo is hosting three flagship events at the Belgium House encapsulating Belgium's commitment to drive progress for all by embracing openness , innovation and global partnerships.
On Tuesday, Belgium demonstrated its green transition leadership during the "Clean Tech Innovation on the Road to Net Zero" discussion.
"Davos is the perfect forum to invite others to join us in uncovering sustainable and innovative solutions for global challenges."

Davos '24: Bill Gates Joins Belgium in Showcase of Innovation and Global Partnerships

Retrieved on:

Wednesday, January 17, 2024

The Belgium House is an initiative from European Business Summits and a group of leading Belgian companies, with the support of the Belgian federal government, to showcase Belgian technology and innovation.

Key Points:

The Belgium House is an initiative from European Business Summits and a group of leading Belgian companies, with the support of the Belgian federal government, to showcase Belgian technology and innovation.
Prime Minister Alexander De Croo is hosting three flagship events at the Belgium House encapsulating Belgium's commitment to drive progress for all by embracing openness , innovation and global partnerships.
On Tuesday, Belgium demonstrated its green transition leadership during the "Clean Tech Innovation on the Road to Net Zero" discussion.
"Davos is the perfect forum to invite others to join us in uncovering sustainable and innovative solutions for global challenges."

Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline

Retrieved on:

Friday, January 5, 2024

DSM-IV codes, Spinocerebellar ataxia, Biotechnology, Research, SCA1, HD, Therapy, BNP Paribas Fortis, Investment, SCA3, Patient, Safety, Ackermans & van Haaren, Huntington's disease, Pharmaceutical industry

"This financing positions us to accelerate our efforts to advance our lead program VO659, currently in a Phase 1/2a clinical study of patients with spinocerebellar ataxia types 3 and 1 and Huntington's disease," said Micah Mackison, chief executive officer at Vico.

Key Points:

"This financing positions us to accelerate our efforts to advance our lead program VO659, currently in a Phase 1/2a clinical study of patients with spinocerebellar ataxia types 3 and 1 and Huntington's disease," said Micah Mackison, chief executive officer at Vico.
The financing will also help support discovery and research efforts to further expand the company's pipeline in other genetic neurological diseases.
The company also announced that Jeroen Vangindertael, Ph.D., investment manager at AvH, will join Vico's board of directors.
"We are proud to support Vico in this financing round as they continue to advance their lead clinical program and further develop a portfolio of novel antisense oligonucleotides," said Dr. Vangindertael.

Cloud Group partners with DIDWW to expand VoIP availability across international markets

Retrieved on:

Tuesday, September 27, 2022

Cloud, BEL20, Voice over IP, Organization, SLA, Partnership, Ackermans & van Haaren, SMS, IP, API, Mol, Solution, Human, SIP, PSTN, PBX, De Tijd, Communication, Mobile phone, Euronext

As experts in the domain of virtual phone systems, Cloud Group offers solutions for businesses of all sizes.

Key Points:

As experts in the domain of virtual phone systems, Cloud Group offers solutions for businesses of all sizes.
Cloud Group's PBX solutions are developed in-house, which ensures unlimited service options and custom configurations for organizations of any type.
DIDWW's extensive phone number coverage and SIP trunking solution with flexible settings have enabled Cloud Group customers toefficiently migrate from traditional PSTN services to modern IP-based telephony in multiple markets.
According to Mike Mol, Sales Director at Cloud Group, this collaboration with DIDWW has opened up new opportunities to efficiently expand across international markets.

Cloud Group partners with DIDWW to expand VoIP availability across international markets

Retrieved on:

Tuesday, September 27, 2022

Cloud, BEL20, Voice over IP, Organization, SLA, Partnership, Ackermans & van Haaren, SMS, IP, API, Mol, Solution, Human, SIP, PSTN, PBX, De Tijd, Communication, Mobile phone, Euronext

As experts in the domain of virtual phone systems, Cloud Group offers solutions for businesses of all sizes.

Key Points:

As experts in the domain of virtual phone systems, Cloud Group offers solutions for businesses of all sizes.
Cloud Group's PBX solutions are developed in-house, which ensures unlimited service options and custom configurations for organizations of any type.
DIDWW's extensive phone number coverage and SIP trunking solution with flexible settings have enabled Cloud Group customers toefficiently migrate from traditional PSTN services to modern IP-based telephony in multiple markets.
According to Mike Mol, Sales Director at Cloud Group, this collaboration with DIDWW has opened up new opportunities to efficiently expand across international markets.

Dr. Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax

Retrieved on:

Monday, September 26, 2022

Hepatitis, BNP Paribas Fortis, Vaccine, Biohub, Ackermans & van Haaren, GlaxoSmithKline, Johnson & Johnson, Investment, Rabies, CEO, Technology, Board of directors, Leadership, MB, Board, Infection, Pharmaceutical industry

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company.

Key Points:

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company.
With this seed capital and the support of Dr Bolger, AstriVax will continue to build its innovative plug-and-play vaccine platform and bring its first vaccines to the clinical development stage.
Leuven, Belgium, 26 September 2022 AstriVax has announced that Dr Jeanne Bolger will chair its Board of Directors as non-executive independent director.
As the new Chair of the AstriVax Board, doctor and biotech investor Jeanne Bolger brings extensive experience in the pharmaceutical industry, with management roles across R&D, commercial and business development, and venture investments.

KU Leuven spin-off AstriVax raises € 30 million seed capital to build vaccine platform

Retrieved on:

Thursday, August 25, 2022

Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked to Belgium-based university KU Leuven.

Key Points:

Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked to Belgium-based university KU Leuven.
Leuven, Belgium, 25 August 2022 Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of KU Leuven spin-offs.
The company will also continue to build its highly innovative, first-in-class plug-and-play vaccine platform based on the ground-breaking work of co-founders Professor Johan Neyts and Kai Dallmeier, PhD, from the KU Leuven Rega Institute.
From 2005 to 2021, KU Leuven invested 21.7 million in its spin-off companies, and 1.46 billion of external capital was raised.